What You Should Know: - Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M. - The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society. Using DNA Fragmentomics Technology to Detect
Read More
Femtech Startup Nanopath Raises $10M to Develop POC Diagnostics for Women’s Health
What You Should Know: - Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes raises $10M in Series A funding, co-led by co-led by Norwest Venture Partners and Medtech Convergence Fund, to develop a point-of-care diagnostics platform for women’s health screenings. - The company plans to use the latest round of funding to support development and commercialization of Nanopath's biosensing platform that aims to transform how women's pelvic and
Read More
Healthcare & Life Science M&A Activity Plummets 1H’22
What You Should Know: - The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%. - Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The report reveals credit markets likely to tighten, but a healthy level of M&A is expected to continue in the growing and defensive healthcare sector. Key Trends and
Read More
BillionToOne Raises $125M to Expand Genetic Testing Platform
What You Should Know: - BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all raises $125M in Series C funding co-led by Adams Street Partners and existing investor Hummingbird Ventures with significant participation from Baillie Gifford, Neotribe Ventures, Norwest Venture Partners, Civilization Ventures, Fifty Years VC, Pacific 8 Ventures, Time BioVentures, and Libertus Capital, among others. - This
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force
What You Should Know: - More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic. - The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More
Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019
- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter. Q1 M&A Activity Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More
CareDx Acquires OTTR for $16M to Enable EMR Integrations at Transplant Centers
CareDx, Inc., a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients has agreed to acquire OTTR Complete Transplant Management (“OTTR”), a provider of organ transplant patient tracking software.Financial DetailsCareDx will pay approximately $16M to acquire OTTR and intends to fund the transaction with cash on hand. For the full year 2019, OTTR’s revenue is projected to be
Read More
Octave Bioscience Grabs $14M for Care Management Platform Focused on Neurodegenerative Diseases
Octave Bioscience lands $14M to bring expertise in chronic neurodegenerative markets and molecular Insights for improved care.Octave Bioscience, a Menlo Park, CA-based developer of a fully integrated care management platform delivering powerful insights for patients with neurodegenerative diseases, today announced it has raised $14 million in Series A funding. The round was led by BCBS Venture Partners with participation from Echo Health Ventures (a strategic collaboration of Cambia Health
Read More
University of Michigan, Tempus Partner on Personalized Breast Cancer Medicine Initiative
Breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women. In 2017, it is estimated that more than 250,000 U.S. women will be diagnosed with new cases of invasive breast cancer. That’s why the University of Michigan Comprehensive Cancer Center has partnered with Tempus on a personalized cancer medicine initiative aimed providing most effective care for individuals diagnosed with breast cancer.As part of the initiative, Tempus will use
Read More
